Artigo Produção Nacional Revisado por pares

Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells

2014; Elsevier BV; Volume: 154; Issue: 1-3 Linguagem: Inglês

10.1016/j.schres.2014.02.007

ISSN

1573-2509

Autores

Bruna Paulsen, Simone C. Cardoso, Mariana P. Stelling, Daniel Veloso Cadilhe, Stevens K. Rehen,

Tópico(s)

Bipolar Disorder and Treatment

Resumo

Schizophrenia has been considered a devastating clinical syndrome rather than a single disease. Nevertheless, the mechanisms behind the onset of schizophrenia have been only partially elucidated. Several studies propose that levels of trace elements are abnormal in schizophrenia; however, conflicting data generated from different biological sources prevent conclusions being drawn. In this work, we used synchrotron radiation X-ray microfluorescence spectroscopy to compare trace element levels in neural progenitor cells (NPCs) derived from two clones of induced pluripotent stem cell lines of a clozapine-resistant schizophrenic patient and two controls. Our data reveal the presence of elevated levels of potassium and zinc in schizophrenic NPCs. Neural cells treated with valproate, an adjunctive medication for schizophrenia, brought potassium and zinc content back to control levels. These results expand the understanding of atomic element imbalance related to schizophrenia and may provide novel insights for the screening of drugs to treat mental disorders.

Referência(s)
Altmetric
PlumX